SCHEMBL692168

SCHEMBL692168

C=CCNC([O])=S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9819151 0.77 ALDH1A1 (0.62)
SCHEMBL325076 0.77 ALDH1A1 (0.62)
Allylthiourea SCHEMBL27561760 0.75 TSHR (0.82)
Iodide SCHEMBL8715119 0.74 ALDH1A1 (0.59)
SCHEMBL36968 0.74
SCHEMBL290485 0.74
SCHEMBL29987 0.74
SCHEMBL9482524 0.72
SCHEMBL4027523 0.72
SCHEMBL10695320 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 127 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014070774-A1 METHODS OF GENERATING BETA-LACTAMASE RESISTANT CARBAPENEM COMPOUNDS SOUTHERN METHODIST UNIVERSITY (US) 2014-05-08 WO claimed
US-20140121192-A1 METHODS OF GENERATING BETA-LACTAMASE RESISTANT CARBAPENEM COMPOUNDS SOUTHERN METHODIST UNIVERSITY (US) 2014-05-01 US claimed
EP-2167081-B1 BACTERICIDAL ANTI-MRSA ACTIVE PHARMACEUTICAL COMPOSITION CONTAINING CARBAPENEMS PFAENDLER HANS RUDOLF (DE) 2013-06-26 EP claimed
EP-1740551-B9 HETEROCYCLIC AMIDE COMPOUND AND USE THEREOF AS AN MMP-13 INHIBITOR TAKEDA PHARMACEUTICAL (JP) 2013-01-16 EP claimed
EP-1740551-B1 HETEROCYCLIC AMIDE COMPOUND AND USE THEREOF AS AN MMP-13 INHIBITOR TAKEDA PHARMACEUTICAL (JP) 2012-09-12 EP claimed
EP-1953148-B1 HETEROCYCLIC AMIDE COMPOUND AND USE THEREOF TAKEDA PHARMACEUTICAL (JP) 2012-02-29 EP claimed
US-20100173887-A1 BACTERICIDAL ANTI-MRSA ACTIVE PHARMACEUTICAL COMPOSITION CONTAINING CARBAPENEMS PFAENDLER HANS RUDOLF 2010-07-08 US claimed
EP-2167081-A1 BACTERICIDAL ANTI-MRSA ACTIVE PHARMACEUTICAL COMPOSITION CONTAINING CARBAPENEMS Pfaendler, Hans Rudolf (DE) 2010-03-31 EP claimed
EP-2126083-A1 HOOGSTEEN-TYPE TRIPLEX FORMATION OF PYRENE LABELLED PROBES FOR NUCLEIC ACID DETECTION IN FLUORESCENCE ASSAY Pedersen, Erik Bjerregaard (DK) 2009-12-02 EP claimed
WO-2008141764-A1 BACTERICIDAL ANTI-MRSA ACTIVE PHARMACEUTICAL COMPOSITION CONTAINING CARBAPENEMS PFAENDLER HANS RUDOLF (DE) 2008-11-27 WO claimed
EP-0548790-B1 (1'S)-Hydroxyalkyloxapenem-3-carboxylic acids and their use as beta-lactamase inhibitors LILLY CO ELI (US) 1996-05-01 EP claimed
US-5461060-A Antiretroviral activity MITSUBISHI KASEI CORPORATION (JP) 1995-10-24 US claimed
EP-0362622-B1 Use of stable oxapenem-3-carboxylic acids for the manufacture of beta-lactamase inhibiting medicaments LILLY CO ELI (US) 1995-03-29 EP claimed
EP-0301394-B1 STABLE OXAPENEM-3-CARBOXYLIC ACIDS Pfaendler, Hans Rudolf, Prof. Dr. (DE) 1993-10-06 EP claimed
EP-0548790-A1 (1'S)-Hydroxyalkyloxapenem-3-carboxylic acids and their use as beta-lactamase inhibitors ELI LILLY AND COMPANY (US) 1993-06-30 EP claimed
US-5108747-A STABLE OXPENEM-3-CARBOXYLIC ACIDS AS BETA-LACTAMASE INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 1992-04-28 US claimed
US-5096899-A Nonhydrolyzing oxapenicillins BAYER AKTIENGESELLSCHAFT (DE) 1992-03-17 US claimed
EP-0420763-A2 6-Substituted acyclopyrimidine nucleoside derivatives and antiviral agent containing the same as active ingredient thereof Mitsubishi Chemical Corporation (JP) 1991-04-03 EP claimed
EP-0000640-B1 TETRAHYDRO-S-TRIAZINE THIONES, PROCESS FOR THEIR PREPARATION AND ACARICIDAL COMPOSITIONS CONTAINING THEM. Pfizer Limited (GB) 1981-06-03 EP claimed
EP-0000640-A1 Tetrahydro-s-triazine thiones, process for their preparation and acaricidal compositions containing them. Pfizer Limited (GB) 1979-02-07 EP claimed